Cervical cancer therapies: Current challenges and future perspectives

Cervical cancer therapies: Current challenges and future perspectives

Cervical cancer is the fourth most common female cancer worldwide and results in over 300 000 deaths globally. The causative agent of cervical cancer is persistent infection with high-risk subtypes of the human papillomavirus and the E5, E6 and E7 viral oncoproteins cooperate with host factors to in...

Full description

Bibliographic Details
Main Authors: Carly A. Burmeister, Saif F. Khan, Georgia Schäfer, Nomonde Mbatani, Tracey Adams, Jennifer Moodley, Sharon Prince
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Tumour Virus Research
Subjects:
Cervical cancer
HPV E6/E7 oncoproteins
Targeted therapy
HPV therapeutic Vaccines
Immune checkpoint inhibitors
Combination therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666679022000040

Internet

http://www.sciencedirect.com/science/article/pii/S2666679022000040

Similar Items